Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050.
- DOI
- 10.1080/14796694.2024.2404762
- Published
- 2024
- Container
- Future oncology (London, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/14796694.2024.2404762,
title = {Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050.},
author = {Pu X and Li J and Zhang B and Zhang J and K Mok TS and Nakagawa K and Rosell R and Cheng Y and Zhou X and Miglorino MR and Niho S and Lee KH and Corral J and Pluzanski A and Li J and Linke R and Pan F and Tang Y and Tan W and Wu L},
year = {2024},
journal = {Future oncology (London, England)},
doi = {10.1080/14796694.2024.2404762},
url = {https://doi.org/10.1080/14796694.2024.2404762}
}RIS
TY - JOUR TI - Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050. AU - Pu X AU - Li J AU - Zhang B AU - Zhang J AU - K Mok TS AU - Nakagawa K AU - Rosell R AU - Cheng Y AU - Zhou X AU - Miglorino MR AU - Niho S AU - Lee KH AU - Corral J AU - Pluzanski A AU - Li J AU - Linke R AU - Pan F AU - Tang Y AU - Tan W AU - Wu L PY - 2024 JO - Future oncology (London, England) DO - 10.1080/14796694.2024.2404762 UR - https://doi.org/10.1080/14796694.2024.2404762 ER -
APA
X, P., J, L., B, Z., J, Z., TS, K. M., K, N., R, R., Y, C., X, Z., MR, M., S, N., KH, L., J, C., A, P., J, L., R, L., F, P., Y, T., W, T., & L, W. (2024). Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050.. Future oncology (London, England). https://doi.org/10.1080/14796694.2024.2404762
Source records
- pubmed · retrieved 2026-09-26T02:49:27.641Z